These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 28824299
1. Diagnostic Value of Gadoxetic Acid-Enhanced MR Imaging to Distinguish HCA and Its Subtype from FNH: A Systematic Review. Guo Y, Li W, Cai W, Zhang Y, Fang Y, Hong G. Int J Med Sci; 2017; 14(7):668-674. PubMed ID: 28824299 [Abstract] [Full Text] [Related]
2. The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis. Suh CH, Kim KW, Kim GY, Shin YM, Kim PN, Park SH. Eur Radiol; 2015 Apr; 25(4):950-60. PubMed ID: 25537979 [Abstract] [Full Text] [Related]
3. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia. Vanhooymissen IJSML, Thomeer MG, Braun LMM, Gest B, van Koeverden S, Willemssen FE, Hunink M, De Man RA, Ijzermans JN, Dwarkasing RS. J Magn Reson Imaging; 2019 Mar; 49(3):700-710. PubMed ID: 30252977 [Abstract] [Full Text] [Related]
4. Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis. Kim TH, Woo S, Ebrahimzadeh S, McInnes MDF, Gerst SR, Do RK. AJR Am J Roentgenol; 2023 Jan; 220(1):28-38. PubMed ID: 35920706 [Abstract] [Full Text] [Related]
5. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy. Sciarra A, Schmidt S, Pellegrinelli A, Maggioni M, Dondossola D, Pasquier J, Cigala C, Tosi D, Halkic N, Bulfamante G, Viale G, Bosari S, Balabaud C, Bioulac-Sage P, Sempoux C. Liver Int; 2019 Jan; 39(1):158-167. PubMed ID: 30218633 [Abstract] [Full Text] [Related]
6. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI. Auer TA, Walter-Rittel T, Geisel D, Schöning W, Schmelzle M, Müller T, Sinn B, Denecke T, Hamm B, Fehrenbach U. BMC Med Imaging; 2021 Feb 15; 21(1):28. PubMed ID: 33588783 [Abstract] [Full Text] [Related]
7. Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma. Bilreiro C, Soler JC, Ayuso JR, Caseiro-Alves F, Ayuso C. Radiol Med; 2021 Nov 15; 126(11):1379-1387. PubMed ID: 34287759 [Abstract] [Full Text] [Related]
9. Diagnostic Value of Gd-EOB-DTPA-MRI for Hepatocellular Adenoma: A Meta-Analysis. Guo Y, Li W, Xie Z, Zhang Y, Fang Y, Cai W, Hong G. J Cancer; 2017 Nov 15; 8(7):1301-1310. PubMed ID: 28607606 [Abstract] [Full Text] [Related]
10. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia. Cannella R, Rangaswamy B, Minervini MI, Borhani AA, Tsung A, Furlan A. AJR Am J Roentgenol; 2019 Mar 15; 212(3):538-546. PubMed ID: 30557050 [Abstract] [Full Text] [Related]
11. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful? Roux M, Pigneur F, Baranes L, Calderaro J, Chiaradia M, Decaens T, Kastahian S, Charles-Nelson A, Tselikas L, Costentin C, Laurent A, Azoulay D, Mallat A, Rahmouni A, Luciani A. Abdom Radiol (NY); 2018 Jul 15; 43(7):1670-1681. PubMed ID: 29110059 [Abstract] [Full Text] [Related]
12. Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review. McInnes MD, Hibbert RM, Inácio JR, Schieda N. Radiology; 2015 Nov 15; 277(2):413-23. PubMed ID: 26020440 [Abstract] [Full Text] [Related]
13. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions. Reizine E, Amaddeo G, Pigneur F, Baranes L, Legou F, Mulé S, Zegai B, Roche V, Laurent A, Rahmouni A, Calderaro J, Luciani A. Eur Radiol; 2018 Oct 15; 28(10):4243-4253. PubMed ID: 29721686 [Abstract] [Full Text] [Related]
14. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI. Roux M, Pigneur F, Calderaro J, Baranes L, Chiaradia M, Tselikas L, Decaens T, Costentin C, Laurent A, Azoulay D, Mallat A, Zafrani ES, Rahmouni A, Luciani A. J Magn Reson Imaging; 2015 Nov 15; 42(5):1249-58. PubMed ID: 25851028 [Abstract] [Full Text] [Related]
15. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. Agarwal S, Fuentes-Orrego JM, Arnason T, Misdraji J, Jhaveri KS, Harisinghani M, Hahn PF. AJR Am J Roentgenol; 2014 Oct 15; 203(4):W408-14. PubMed ID: 25055198 [Abstract] [Full Text] [Related]
16. Value of discrepancy of the central scar-like structure between dynamic CT and gadoxetate disodium-enhanced MRI in differentiation of focal nodular hyperplasia and hepatocellular adenoma. Park HJ, Byun JH, Kang JH, Kang HJ, Yu E, Lee SJ, Kim SY, Won HJ, Shin YM, Kim PN. Eur J Radiol; 2021 Jun 15; 139():109730. PubMed ID: 33930719 [Abstract] [Full Text] [Related]
17. Association Between Gadoxetic Acid-Enhanced Magnetic Resonance Imaging, Organic Anion Transporters, and Farnesoid X Receptor in Benign Focal Liver Lesions. van Rosmalen BV, Visentin M, Furumaya A, van Delden OM, Kazemier G, van Gulik TM, Verheij J, Stieger B. Drug Metab Dispos; 2024 Jan 09; 52(2):118-125. PubMed ID: 38050024 [Abstract] [Full Text] [Related]